Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Roxanis

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pathology|January 17, 2013
Occurrence and significance of epithelial-mesenchymal transition in breast cancerIoannis Roxanis
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2010
Cellular cohesion as a prognostic factor in malignant melanoma: a retrospective study with up to 12 years follow-upIoannis Roxanis, Jade Chow
Journal of Neuroimmunology|April 19, 2002
Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesisIoannis Roxanis, Kingsley Micklem, John McConville, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 28, 2023
Next-Generation Sequencing and Image-Guided Tissue Sampling: A Primer for Interventional RadiologistsJason Yeung, Nicos Fotiadis, Athanasios Diamantopoulos, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 9, 2021
Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncologyFaranak Sobhani, Ruth Robinson, Azam Hamidinekoo, et al.
Frontiers in Oncology|February 8, 2021
SuperHistopath: A Deep Learning Pipeline for Mapping Tumor Heterogeneity on Low-Resolution Whole-Slide Digital Histopathology ImagesKonstantinos Zormpas-Petridis, Rosa Noguera, Daniela Kolarevic Ivankovic, et al.
Frontiers in Oncology|November 5, 2019
Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma HistopathologyKonstantinos Zormpas-Petridis, Henrik Failmezger, Shan E Ahmed Raza, et al.
Oncotarget|February 19, 2015
Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancerWing-yin Leung, Ioannis Roxanis, Helen Sheldon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2012
Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor modelGabriela Kramer-Marek, Merel Gijsen, Dale O Kiesewetter, et al.
Clinical Breast Cancer|March 9, 2022
Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening UnitSoha El Sheikh, Michael Rathbone, Khurram Chaudhary, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pathology|January 17, 2013
Occurrence and significance of epithelial-mesenchymal transition in breast cancerIoannis Roxanis
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2010
Cellular cohesion as a prognostic factor in malignant melanoma: a retrospective study with up to 12 years follow-upIoannis Roxanis, Jade Chow
Journal of Neuroimmunology|April 19, 2002
Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesisIoannis Roxanis, Kingsley Micklem, John McConville, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 28, 2023
Next-Generation Sequencing and Image-Guided Tissue Sampling: A Primer for Interventional RadiologistsJason Yeung, Nicos Fotiadis, Athanasios Diamantopoulos, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 9, 2021
Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncologyFaranak Sobhani, Ruth Robinson, Azam Hamidinekoo, et al.
Frontiers in Oncology|February 8, 2021
SuperHistopath: A Deep Learning Pipeline for Mapping Tumor Heterogeneity on Low-Resolution Whole-Slide Digital Histopathology ImagesKonstantinos Zormpas-Petridis, Rosa Noguera, Daniela Kolarevic Ivankovic, et al.
Frontiers in Oncology|November 5, 2019
Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma HistopathologyKonstantinos Zormpas-Petridis, Henrik Failmezger, Shan E Ahmed Raza, et al.
Oncotarget|February 19, 2015
Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancerWing-yin Leung, Ioannis Roxanis, Helen Sheldon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2012
Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor modelGabriela Kramer-Marek, Merel Gijsen, Dale O Kiesewetter, et al.
Clinical Breast Cancer|March 9, 2022
Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening UnitSoha El Sheikh, Michael Rathbone, Khurram Chaudhary, et al.
Pageof 4